262 related articles for article (PubMed ID: 35281827)
1. Evaluation of the Prognostic Relevance of Differential Claudin Gene Expression Highlights Claudin-4 as Being Suppressed by TGFβ1 Inhibitor in Colorectal Cancer.
Yang L; Zhang W; Li M; Dam J; Huang K; Wang Y; Qiu Z; Sun T; Chen P; Zhang Z; Zhang W
Front Genet; 2022; 13():783016. PubMed ID: 35281827
[No Abstract] [Full Text] [Related]
2. Claudin gene expression profiles and clinical value in colorectal tumors classified according to their molecular subtype.
Cherradi S; Martineau P; Gongora C; Del Rio M
Cancer Manag Res; 2019; 11():1337-1348. PubMed ID: 30863148
[TBL] [Abstract][Full Text] [Related]
3. Identification of claudin‑1, ‑3, ‑7 and ‑8 as prognostic markers in human laryngeal carcinoma.
Zhou S; Piao X; Wang C; Wang R; Song Z
Mol Med Rep; 2019 Jul; 20(1):393-400. PubMed ID: 31115553
[TBL] [Abstract][Full Text] [Related]
4. Dysregulation of Claudin family genes in colorectal cancer in a Chinese population.
Tang W; Dou T; Zhong M; Wu Z
Biofactors; 2011; 37(1):65-73. PubMed ID: 21294205
[TBL] [Abstract][Full Text] [Related]
5. Claudin expression in breast cancer: high or low, what to expect?
Ricardo S; Gerhard R; Cameselle-Teijeiro JF; Schmitt F; Paredes J
Histol Histopathol; 2012 Oct; 27(10):1283-95. PubMed ID: 22936447
[TBL] [Abstract][Full Text] [Related]
6. Identification of key claudin genes associated with survival prognosis and diagnosis in colon cancer through integrated bioinformatic analysis.
Alghamdi RA; Al-Zahrani MH
Front Genet; 2023; 14():1221815. PubMed ID: 37799140
[TBL] [Abstract][Full Text] [Related]
7. Identification of claudin-2, -6, -11 and -14 as prognostic markers in human breast carcinoma.
Jia H; Chai X; Li S; Wu D; Fan Z
Int J Clin Exp Pathol; 2019; 12(6):2195-2204. PubMed ID: 31934042
[TBL] [Abstract][Full Text] [Related]
8. Claudins and hepatocellular carcinoma.
Wang W; Zhou Y; Li W; Quan C; Li Y
Biomed Pharmacother; 2024 Feb; 171():116109. PubMed ID: 38185042
[TBL] [Abstract][Full Text] [Related]
9. A CLDN1-negative phenotype predicts poor prognosis in triple-negative breast cancer.
Ma F; Ding X; Fan Y; Ying J; Zheng S; Lu N; Xu B
PLoS One; 2014; 9(11):e112765. PubMed ID: 25393310
[TBL] [Abstract][Full Text] [Related]
10. Association of CLDN6 and CLDN10 With Immune Microenvironment in Ovarian Cancer: A Study of the Claudin Family.
Gao P; Peng T; Cao C; Lin S; Wu P; Huang X; Wei J; Xi L; Yang Q; Wu P
Front Genet; 2021; 12():595436. PubMed ID: 34249076
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of expression and prognostic value of the claudin family in human breast cancer.
Yang G; Jian L; Chen Q
Aging (Albany NY); 2021 Mar; 13(6):8777-8796. PubMed ID: 33714203
[TBL] [Abstract][Full Text] [Related]
12. Claudins and Gastric Cancer: An Overview.
Hashimoto I; Oshima T
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053454
[TBL] [Abstract][Full Text] [Related]
13. Claudin-1 Protein Expression Is a Good Prognostic Factor in Non-Small Cell Lung Cancer, but only in Squamous Cell Carcinoma Cases.
Moldvay J; Fábián K; Jäckel M; Németh Z; Bogos K; Furák J; Tiszlavicz L; Fillinger J; Döme B; Schaff Z
Pathol Oncol Res; 2017 Jan; 23(1):151-156. PubMed ID: 27687058
[TBL] [Abstract][Full Text] [Related]
14. Claudin-6 and claudin-9 function as additional coreceptors for hepatitis C virus.
Zheng A; Yuan F; Li Y; Zhu F; Hou P; Li J; Song X; Ding M; Deng H
J Virol; 2007 Nov; 81(22):12465-71. PubMed ID: 17804490
[TBL] [Abstract][Full Text] [Related]
15. The claudin gene family: expression in normal and neoplastic tissues.
Hewitt KJ; Agarwal R; Morin PJ
BMC Cancer; 2006 Jul; 6():186. PubMed ID: 16836752
[TBL] [Abstract][Full Text] [Related]
16. The Expression of the Claudin Family of Proteins in Colorectal Cancer.
Cox KE; Liu S; Hoffman RM; Batra SK; Dhawan P; Bouvet M
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540693
[TBL] [Abstract][Full Text] [Related]
17. Knocking down claudin receptors leads to a decrease in prostate cancer cell migration, cell growth, cell viability and clonogenic cell survival.
Liu Q; Shen H; Naguib A; Weiss RM; Martin DT
Mol Biomed; 2021 Oct; 2(1):31. PubMed ID: 35006480
[TBL] [Abstract][Full Text] [Related]
18. Claudin-4-targeted therapy using Clostridium perfringens enterotoxin for prostate cancer.
Maeda T; Murata M; Chiba H; Takasawa A; Tanaka S; Kojima T; Masumori N; Tsukamoto T; Sawada N
Prostate; 2012 Mar; 72(4):351-60. PubMed ID: 21656836
[TBL] [Abstract][Full Text] [Related]
19. Claudin-1, -3 and -4 proteins and mRNA expression in benign and malignant breast lesions: a research study.
Tokés AM; Kulka J; Paku S; Szik A; Páska C; Novák PK; Szilák L; Kiss A; Bögi K; Schaff Z
Breast Cancer Res; 2005; 7(2):R296-305. PubMed ID: 15743508
[TBL] [Abstract][Full Text] [Related]
20. Potential roles of claudin-3 and claudin-4 in ovarian cancer management.
Uthayanan L; El-Bahrawy M
J Egypt Natl Canc Inst; 2022 Jun; 34(1):24. PubMed ID: 35665865
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
